Clinical Trials
10 trialsNCT06249672 2026-05-05
PRESERVE
Insel Gruppe AG, University Hospital Bern
Recruiting
NCT06209099 2025-06-12
Organ Preservation First Strategy and Intentional Watch and Wait for MRI Defined Low-risk Rectal Cancer
Peking University Cancer Hospital & Institute
Phase NA Recruiting
NCT06395337 2024-05-02
MIRCA & MIPAC
Radboud University Medical Center
Phase 1/2 Unknown
NCT05969847 2023-08-01
TRACE-LE
Fujian Medical University Union Hospital
Phase 2 Not yet recruiting
NCT05772923 2023-03-17
OPAXX
The Netherlands Cancer Institute
Phase NA Recruiting
NCT02860234 2021-07-23
Tailored Operative or Non-operative Management for Low-risk Rectal Cancer After Intensive Neoadjuvant Treatment
Peking University Cancer Hospital & Institute
Completed
NCT04405206 2020-10-14
BJCC-R01
Peking University Cancer Hospital & Institute
Unknown
NCT03548844 2018-06-07
Local Excision Versus Total Mesorectal Excision In Pathological Complete Response (ypT0-1cN0) Mid- Or Low-Rectal Cancer After Neoadjuvant Therapy
Sun Yat-sen University
Phase NA Unknown
NCT03038217 2017-02-03
Investigation of the Value of ctDNA in Diagnosis, Treatment, and Surveillance of Surgically Resectable Colorectal Cancer
Peking Union Medical College Hospital
Phase 3 Unknown
NCT02490709 2015-07-07
Local Excision of Clinical T3 Rectal Adenocarcinoma Showing Major Response(ycT0-1) After Neoadjuvant Chemoradiotherapy
National Cancer Center, Korea
Phase 2 Unknown